GLP1 offerings emphasize injectable compounded semaglutide and tirzepatide shipped through compounding pharmacies, with cancellation limits once started
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose
Him & Hers is also one of the companies involved with Novos Wegovy subscription plan, the first and only of its kind that the manufacturer says could save patients up to $1,200 annually.
Supports Steadier Hydration and Blood Pressure: Many patients find their bodies hold water more evenly, decreasing sudden spikes in blood pressure
The MDL had 37 pending cases as of February 2026 and is growing rapidly
The 72-week STEP UP trial was a randomised, double-blinded, parallel-group, placebo-controlled, superiority trial designed to evaluate the efficacy and safety of semaglutide 7.2 mg compared to semaglutide 2.4 mg and placebo as an adjunct to lifestyle intervention
00032-X/asset/f312f4e3-50d1-472f-90c9-896e4cef8e23/main.assets/gr1_lrg.jpg)
